Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Tempest Therapeutics, Inc. (OVAS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Revenues  0.00.00.00.00.00.00.014.4
            Revenue growth     -100.0%-100.0%-100.0%-100.0%-79.9%
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.00.00.00.00.00.00.014.4
            Gross margin         100.0%
Selling, general and administrative   [+]11.912.012.111.611.911.39.810.7
Research and development  20.922.122.521.420.118.717.216.1
EBITDA   [+]-32.1-33.4-34.0-32.5-31.6-29.6-26.6-12.2
            EBITDA margin         -84.7%
Depreciation and amortization  0.60.70.60.50.40.40.40.3
EBIT   [+]-32.8-34.1-34.6-33.0-32.0-30.0-27.0-12.5
            EBIT margin         -86.9%
Interest expense  1.51.61.61.51.61.41.30.9
Other income (expense), net   [+]1.00.80.50.20.00.00.0-14.5
Pre-tax income  -33.3-34.9-35.7-34.4-33.5-31.4-28.3-27.9
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -33.3-34.9-35.7-34.4-33.5-31.4-28.3-27.9
            Net margin         -194.3%
   
Basic EPS   [+]($2.51)($2.76)($3.25)($3.80)($4.59)($6.76)($9.48)($4.13)
Diluted EPS   [+]($2.51)($2.76)($3.25)($3.80)($4.59)($6.76)($9.48)($4.13)
   
Shares outstanding (basic)   [+]13.312.611.09.07.34.73.06.8
Shares outstanding (diluted)   [+]13.312.611.09.07.34.73.06.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy